| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 138.08B | 135.63B | 129.29B | 109.33B | 109.64B | 117.22B |
| Gross Profit | 23.24B | 23.01B | 18.77B | 15.51B | 15.75B | 17.61B |
| EBITDA | 13.38B | 13.49B | 8.96B | 6.75B | 7.43B | 9.16B |
| Net Income | 8.07B | 8.22B | 5.05B | 3.79B | 4.54B | 5.59B |
Balance Sheet | ||||||
| Total Assets | 117.17B | 132.57B | 123.98B | 116.08B | 93.10B | 95.42B |
| Cash, Cash Equivalents and Short-Term Investments | 13.33B | 22.10B | 11.16B | 9.35B | 9.95B | 10.46B |
| Total Debt | 9.47B | 19.57B | 21.09B | 30.86B | 10.62B | 10.92B |
| Total Liabilities | 60.02B | 74.68B | 71.81B | 68.21B | 47.56B | 53.20B |
| Stockholders Equity | 57.14B | 57.88B | 52.17B | 47.87B | 45.53B | 42.22B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 14.95B | 13.94B | -18.31B | 1.31B | -4.41B |
| Operating Cash Flow | 0.00 | 15.95B | 15.94B | -16.71B | 2.60B | -3.68B |
| Investing Cash Flow | 0.00 | -807.00M | -1.92B | -1.96B | -1.15B | -675.00M |
| Financing Cash Flow | 0.00 | -4.21B | -12.22B | 18.06B | -1.97B | -664.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥115.40B | 11.04 | ― | 2.81% | -3.99% | 13.29% | |
79 Outperform | ¥91.93B | 15.89 | ― | 3.63% | 35.73% | 62.37% | |
76 Outperform | ¥185.90B | 10.32 | ― | 3.44% | 11.25% | 36.92% | |
75 Outperform | ¥131.97B | 8.40 | ― | 3.13% | 5.39% | 33.02% | |
75 Outperform | ¥236.15B | 8.46 | ― | 3.82% | -3.72% | 59.02% | |
68 Neutral | ¥152.95B | 9.00 | ― | 2.89% | 20.38% | 128.85% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |